Healthcare IT News – The National Institutes of Health’s Genomic Working Group said researchers should build the program in a systemic way before reaching the planned 1 million participants.
NPR – The last time the U.S. life expectancy dropped was in 1993 because of the AIDS epidemic. Life expectancy hasn't fallen two years in a row in the U.S. since the early 1960s.
NBC News – A computer-based system designed to prevent train accidents has been stalled by high costs and technological hurdles. It was not being used by the train that derailed in Washington state, killing at least three people.
The Washington Post – In a historic move, the Food and Drug Administration approved a pioneering gene therapy for a rare form of childhood blindness, the first such treatment cleared in the United States for an inherited disease.
Regulatory Affairs Professionals Society – The FDA published two new draft guidance documents that seek to support the development of treatments that address underlying genetic mutations and to determine if an in vitro diagnostic device must undergo its own FDA review.
Axios – Medicine is poised to be one place where AI makes a mark. In a study published this week, researchers report that a machine algorithm was as good — or better — than pathologists at detecting the spread of a type of breast cancer.
Forbes – A startup says it has discovered a new CRISPR enzyme for editing DNA, one of the hottest areas in biotech. Naturally, it is going to give it away for free.
The Hill – Lawmakers unveiled bipartisan legislation in both the House and Senate on Tuesday aimed at bolstering the development of artificial intelligence (AI).
National Institutes of Health – A new clinical trials consortium funded by the National Institutes of Health is expected to accelerate and expand studies for therapies in Alzheimer’s disease and related dementias.
FierceBiotech – A research team has created a form of CRISPR/Cas9 that can activate targeted genes without making breaks in the DNA. Eliminating the need to physically cut the DNA can cut down on the harmful side effects that might come with CRISPR.